Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value

• Egile Nagusiak: Yoshimitsu Soga (Egilea), Masahiko Fujihara (Egilea), Osamu Iida (Egilea), Anvar Babaev (Egilea), Daizo Kawasaki (Egilea), Thomas Zeller (Egilea), David O'Connor (Egilea), Anna M Chavez (Egilea), Stefan Muller-Hulsbeck (Egilea), Michael R Jaff (Egilea)
• Formatua: Liburua
• Argitaratua: Becaris Publishing Limited, 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Aim: Use long-term follow-up data from the IMPERIAL study to determine whether drug-eluting polymer based nitinol stent treatment can delay the time to repeat intervention for femoropopliteal artery disease and how such a delay may result in cost savings in a value-based episode of care. Patients &a...